Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

HLA Antibodies in Systemic Lupus Erythematosus

Study ID: NCT06921239
Start Date: 2025-05
End Date: 2026-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

University hospital center, Amiens

Source: clinicaltrials.gov

Share:
Add to list

Serious Game to Teach Opioid Overdose Response

Study ID: NCT06727786
Start Date: 2026-02-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

850

Intervention / Treatment

Serious game training

Sponsor

University of Nevada, Reno

Source: clinicaltrials.gov

Share:
Add to list

Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging

Study ID: NCT06177639
Start Date: 2025-07
End Date: 2025-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

42

Intervention / Treatment

Waslo

Volk Pictor Plus ™

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

Study ID: NCT04520139
Start Date: 2025-12
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

N-Acetyl-Cysteine

Placebo

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Acute Myeloid Leukemia (AML)

Study ID: NCT06852222
Start Date: 2025-05-02
End Date: 2029-08-15
Study Type

Interventional

Study Phase

Phase3

No. of Participants

600

Intervention / Treatment

Bleximenib

Venetoclax (VEN)

Azacitidine (don't)

Placebo

Sponsor

Janssen Research & Development, LLC

Source: clinicaltrials.gov

Share:
Add to list

Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients with Inflammatory Bowel Disease

Study ID: NCT06799039
Start Date: 2025-09-01
End Date: 2031-09-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

180

Intervention / Treatment

Xylitol

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Voiceitt for People With Impairments in Speech

Study ID: NCT06874322
Start Date: 2025-05
End Date: 2026-06-26
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Voiceitt

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the EAPOC-COPD System

Study ID: NCT06852339
Start Date: 2025-07-01
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

131

Intervention / Treatment

EAPOC-COPD

Usual Care

Sponsor

Women's College Hospital

Source: clinicaltrials.gov

Share:
Add to list

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

Study ID: NCT05332639
Start Date: 2025-05-01
End Date: 2026-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's) tool

Standard Crohn's Disease Education

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

CongenItal Naevus Cohort for Longitudinal Evaluation

Study ID: NCT06828822
Start Date: 2025-06-01
End Date: 2031-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

819

Intervention / Treatment

Neurodevelopmental assessment

Meeting with the parents

Patient quality of life assessment

Sponsor

Nantes University Hospital

Source: clinicaltrials.gov

Share:
Add to list